诊断后的生活导航:来自早期痴呆症患者的见解
1School of Nursing, University of Northern British Columbia, Quesnel, British Columbia, Canada.
Journal of Alzheimer's disease : JAD
|August 6, 2025
概括
接受阿尔茨海默氏症诊断会对身份和行动能力产生深远的影响. 了解情绪性和身份保护对于个性化的痴呆症护理策略至关重要.
科学领域:
- 神经科学是一个神经科学.
- 心理学 心理学 心理学
- 老年学是一门学科.
背景情况:
- 阿尔茨海默病 (AD) 诊断对认知,身份和代理存在重大挑战.
- 现有的研究往往忽视了早期阿尔茨海默症患者的主观经验.
- 社会情绪选择性和连续性理论为理解适应慢性疾病提供了框架.
研究的目的:
- 探索被诊断患有早期阿尔茨海默病的个人的生活经历.
- 确定影响情绪性和身份保护的关键因素.
- 为制定个人化护理策略提供信息,以支持代理和福祉.
主要方法:
- 定性研究集中在受阿尔茨海默病影响的个人的声音.
- 分析与社会情绪选择性和连续性理论保持一致.
- 评论批判性地反思应对反应和情绪适应.
主要成果:
- 早期阿尔茨海默病诊断显著影响自我认知和控制能力.
- 通过保持身份和目标感来培养情绪弹性.
- 自我的连续性对于应对记忆和认知衰退的挑战至关重要.
结论:
- 个性化护理必须优先保护早期阿尔茨海默病患者的自我意识和行动能力.
- 支持情绪健康和认同与管理认知症状同样重要.
- 需要对情绪适应有细微的理解,以提高痴呆症护理实践.
相关概念视频
Dementia
165
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
165
Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262
Cognitive Development During Adulthood
279
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
279
Parkinson's Disease: Overview
708
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
708
Intellectual Disability
159
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
159


